CO2023018582A2 - Procedimiento para la preparación de diosmina y de fracción flavonoica - Google Patents
Procedimiento para la preparación de diosmina y de fracción flavonoicaInfo
- Publication number
- CO2023018582A2 CO2023018582A2 CONC2023/0018582A CO2023018582A CO2023018582A2 CO 2023018582 A2 CO2023018582 A2 CO 2023018582A2 CO 2023018582 A CO2023018582 A CO 2023018582A CO 2023018582 A2 CO2023018582 A2 CO 2023018582A2
- Authority
- CO
- Colombia
- Prior art keywords
- diosmin
- procedure
- preparation
- flavonoid fraction
- flavonoid
- Prior art date
Links
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 title abstract 3
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 title abstract 2
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 title abstract 2
- 229960004352 diosmin Drugs 0.000 title abstract 2
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 title abstract 2
- 229930003935 flavonoid Natural products 0.000 title abstract 2
- 150000002215 flavonoids Chemical class 0.000 title abstract 2
- 235000017173 flavonoids Nutrition 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 abstract 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 abstract 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 abstract 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 abstract 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 abstract 1
- 229940025878 hesperidin Drugs 0.000 abstract 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Procedimiento para la preparación de Diosmina y de fracción flavonoica por oxidación directa de la hesperidina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21305932 | 2021-07-06 | ||
| PCT/EP2022/068596 WO2023280857A1 (fr) | 2021-07-06 | 2022-07-05 | Procédé de préparation de diosmine et de fraction flavonoïque |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2023018582A2 true CO2023018582A2 (es) | 2024-01-15 |
Family
ID=76920722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2023/0018582A CO2023018582A2 (es) | 2021-07-06 | 2023-12-28 | Procedimiento para la preparación de diosmina y de fracción flavonoica |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4367124A1 (es) |
| KR (1) | KR20240028442A (es) |
| CN (1) | CN117715921A (es) |
| AR (1) | AR126366A1 (es) |
| AU (1) | AU2022307232A1 (es) |
| BR (1) | BR112023027411A2 (es) |
| CA (1) | CA3225209A1 (es) |
| CO (1) | CO2023018582A2 (es) |
| WO (1) | WO2023280857A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH602778A5 (es) | 1975-05-16 | 1978-07-31 | Hommel Ag | |
| FR2782518A1 (fr) | 1998-08-19 | 2000-02-25 | Innokem Sarl | Procede de fabrication industrielle de diosmine a partir de l'hesperidine par reaction avec de l'iode et de la pyridine |
| EP3053930A1 (en) | 2015-02-03 | 2016-08-10 | Interquim, S.A. | Process for the preparation of diosmin |
| EP3321273B1 (en) | 2016-08-30 | 2022-02-23 | Chengdu Okay Pharmaceutical Co., Ltd | Preparation method of diosmin |
-
2022
- 2022-07-04 AR ARP220101742A patent/AR126366A1/es unknown
- 2022-07-05 CA CA3225209A patent/CA3225209A1/fr active Pending
- 2022-07-05 AU AU2022307232A patent/AU2022307232A1/en active Pending
- 2022-07-05 KR KR1020247002784A patent/KR20240028442A/ko unknown
- 2022-07-05 EP EP22744691.1A patent/EP4367124A1/fr active Pending
- 2022-07-05 CN CN202280047828.5A patent/CN117715921A/zh active Pending
- 2022-07-05 BR BR112023027411A patent/BR112023027411A2/pt unknown
- 2022-07-05 WO PCT/EP2022/068596 patent/WO2023280857A1/fr active Application Filing
-
2023
- 2023-12-28 CO CONC2023/0018582A patent/CO2023018582A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR126366A1 (es) | 2023-10-11 |
| CN117715921A (zh) | 2024-03-15 |
| AU2022307232A1 (en) | 2024-01-18 |
| BR112023027411A2 (pt) | 2024-03-12 |
| EP4367124A1 (fr) | 2024-05-15 |
| KR20240028442A (ko) | 2024-03-05 |
| WO2023280857A1 (fr) | 2023-01-12 |
| CA3225209A1 (fr) | 2023-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020015437A2 (es) | Derivados de tetrahidro-imidazo[4,5-c]piridina como inmunomoduladores pd-l1 | |
| CO2018010316A2 (es) | Inmunomoduladores | |
| CL2023001550A1 (es) | Sistemas activos dinámicos acromosómicos. | |
| BR112017018316A2 (pt) | composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral | |
| CO2018008846A2 (es) | Derivados de carboxamida útiles como inhibidores de rsk | |
| UY38003A (es) | Construcciones de arni para inhibir la expresión de pnpla3 y métodos de uso de las mismas | |
| BR112018067525A2 (pt) | anticorpos tendo especificidade para o btla e seus usos | |
| CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
| BR112019017403A2 (pt) | composições e métodos para o tratamento de câncer | |
| CL2015003357A1 (es) | Derivados de nucleósidos 4'-fluoro-2'-metil sustituidos | |
| CO2018008304A2 (es) | Compuestos antiproliferativos y sus composiciones farmacéuticas y usos | |
| UY34725A (es) | Nuevos derivados de tienopirimidina, procesos para su preparación y sus usos terapéuticos. | |
| BR112016016870A8 (pt) | derivados de icariina, seus usos, e composição farmacêutica | |
| BR112021022613A2 (pt) | Métodos de fabricação de canabidiol ou canabidivarina e intermediários de fabricação de canabidiol ou canabidivarina | |
| CL2017002689A1 (es) | Derivados de pirrolidincarboxamido y métodos para prepararlos y usarlos | |
| CO2021010786A2 (es) | Toxinas apxia, apxiia y apxiiia inactivadas | |
| CL2021000855A1 (es) | Replicones basados en alfavirus para la administración de bioterapias. | |
| CL2019001804A1 (es) | Activador de nrf2. | |
| AR115798A1 (es) | Catalizadores para la deshidrogenación oxidativa de alcanos | |
| CL2021001198A1 (es) | Compuestos heteroaromáticos como inhibidores de vanina | |
| ECSP21021189A (es) | Formas de dosificación pediátricas de vitamina d, métodos de elaboración y uso | |
| UY38503A (es) | Constructos de arni para inhibir la expresión de pnpla3 y métodos de uso de estos | |
| CO2022018892A2 (es) | Procedimiento de preparación de la diosmina | |
| BR112017020507A2 (pt) | composição, e, uso de um derivado de éter de isosorbida | |
| CO2023018582A2 (es) | Procedimiento para la preparación de diosmina y de fracción flavonoica |